The use of complementary and alternative medicine in patients with common variable immunodeficiency

Simple item page
dc.contributor.buuauthorKaralı, Yasin
dc.contributor.buuauthorSağlam, Halil
dc.contributor.buuauthorKaralı, Zuhal
dc.contributor.buuauthorKılıç, Sara Şebnem
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Pediatri Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0003-0710-5422tr_TR
dc.contributor.orcid0000-0001-8571-2581tr_TR
dc.contributor.researcheridC-7392-2019tr_TR
dc.contributor.researcheridAAH-1658-2021tr_TR
dc.contributor.scopusid49863694000tr_TR
dc.contributor.scopusid35612700100tr_TR
dc.contributor.scopusid35791967200tr_TR
dc.contributor.scopusid34975059200tr_TR
dc.date.accessioned2022-01-06T12:57:48Z
dc.date.available2022-01-06T12:57:48Z
dc.date.issued2011
dc.description.abstractObjectives: Complementary and alternative medicine (CAM) usage is a reality in patients with chronic diseases, but there are no data on CAM usage in immunodeficiency diseases necessitating intravenous immunoglobulin (IVIG) therapy. The aim of this study was to investigate the rate of CAM usage in patients with common variable immunodeficiency (CVID). Methods: Forty-three patients (29 boys and 14 girls) with CVID and receiving IVIG every 3 weeks were included. Data were collected through a questionnaire completed by the parents. Those using treatments other than their medical therapies that were defined as CAM by the National Center for Complementary and Alternative Medicine were classified as CAM users. Results: The mean (SD) age at diagnosis was 7.56 (9.44) years (range, 6 months to 44 years) and the mean IVIG treatment duration was 6.02 (3.84) years (range, 1 to 20 years). Thirty-six (83.7%) of the 43 patients analyzed had used at least 1 CAM approach. The most common modalities were herbal medicines (65.1%), dietary supplements (62.8%), vitamins (46.5%), and religion (34.9%). Only 11% of those interviewed had informed their doctor that they were using CAM. The most common reason for CAM usage was the desire to improve body resistance. Eighteen parents (50%) claimed that their children had benefited from CAM. Conclusion: Our findings reveal that there is a remarkably high tendency to use CAM in patients with CVID. Although no side effects were reported by the families, potential drug interactions should be considered.en_US
dc.identifier.citationKaralı, Y. vd. (2011). "The use of complementary and alternative medicine in patients with common variable immunodeficiency". Journal of Investigational Allergology and Clinical Immunology, 21(6), 480-483.en_US
dc.identifier.endpage483tr_TR
dc.identifier.issn1018-9068
dc.identifier.issue6tr_TR
dc.identifier.pubmed21995182tr_TR
dc.identifier.scopus2-s2.0-80053959112tr_TR
dc.identifier.startpage480tr_TR
dc.identifier.urihttp://www.jiaci.org/issues/vol21issue6/7.pdf
dc.identifier.urihttp://hdl.handle.net/11452/23912
dc.identifier.volume21tr_TR
dc.identifier.wos000296171000007tr_TR
dc.indexed.pubmedPubmeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherEsmon Publicidaden_US
dc.relation.journalJournal of Investigational Allergology and Clinical Immunologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAllergyen_US
dc.subjectImmunologyen_US
dc.subjectComplementary and alternative medicineen_US
dc.subjectCommon variable immunodeficiencyen_US
dc.subjectImmunodeficiencyen_US
dc.subjectTurkish cancer-patientsen_US
dc.subjectPediatric-patientsen_US
dc.subjectEastern Turkeyen_US
dc.subjectChildrenen_US
dc.subjectTherapiesen_US
dc.subjectPrevalenceen_US
dc.subjectAsthmaen_US
dc.subject.emtreeImmunoglobulinen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeAlternative medicineen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeClinical articleen_US
dc.subject.emtreeCommon variable immunodeficiencyen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeDiet supplementationen_US
dc.subject.emtreeDrug useen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeHerbal medicineen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeImmunopotentiationen_US
dc.subject.emtreeInfanten_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeOutcome assessmenten_US
dc.subject.emtreeSpiritual healingen_US
dc.subject.emtreeTherapy effecten_US
dc.subject.emtreeTreatment durationen_US
dc.subject.emtreeTreatment responseen_US
dc.subject.emtreeVitamin supplementationen_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshAge of onset;en_US
dc.subject.meshChilden_US
dc.subject.meshChild, preschoolen_US
dc.subject.meshCommon variable immunodeficiencyen_US
dc.subject.meshComplementary therapiesen_US
dc.subject.meshCross-sectional studiesen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshInfanten_US
dc.subject.meshMaleen_US
dc.subject.meshQuestionnairesen_US
dc.subject.meshYoung adulten_US
dc.subject.scopusComplementary and Alternative Medicine; Homeopathy; Acupunctureen_US
dc.subject.wosAllergyen_US
dc.subject.wosImmunologyen_US
dc.titleThe use of complementary and alternative medicine in patients with common variable immunodeficiencyen_US
dc.typeArticle
dc.wos.quartileQ2 (Allergy)en_US
dc.wos.quartileQ3 (Immunology)en_US

Files

License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Web of Science
Scopus